Home / Focus Areas / Scientific Research / Miscellaneous

Sherlock Biosciences — Research on Viral Diagnostics

Sherlock Biosciences co-founder Feng Zhang was a co-discoverer of CRISPR. (Photo courtesy Sherlock Biosciences)
Organization Name 
Award Date 
1/2019
Grant Amount 
$17,500,000
Purpose 
To support the development of a diagnostic platform to identify any virus present in a patient sample.
Topic (focus area) 

Grant Investigators: Chris Somerville and Heather Youngs

This page was reviewed but not written by the grant investigators. Sherlock Biosciences staff also reviewed this page prior to publication.

The Open Philanthropy Project recommended a grant of up to $17,500,000 over five years and an additional investment in Sherlock Biosciences to support the development of a diagnostic platform to quickly, easily, and inexpensively identify any human virus present in a patient sample. Development of this technology would represent a significant advance in viral diagnosis, and could both reduce threats from viral pandemics and also benefit health care broadly. Sherlock recently spun out of Harvard University’s Wyss Institute and the Broad Institute of MIT and Harvard.

This falls within our work on scientific research, and specifically within our interest in advancing science supporting biosecurity and pandemic preparedness.